Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 41Obesity 9Anovulation 8Infertility 7Insulin Resistance 6Overweight 2Non-alcoholic Fatty Liver Disease 2Hirsutism 2Diabetes, Gestational 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Racism 1Prostatic Neoplasms 1Pregnancy Complications 1Mouth Neoplasms 1Metabolic Syndrome 1Hyperandrogenism 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1Diabetes Mellitus, Type 2 1Breast Cancer Female 1Body Weight 1Amenorrhea 1Acne Vulgaris 1

Interventions

Medroxyprogesterone Acetate 2semaglutide 1Resistance Training 1Progestins 1Nutrition Assessment 1Metformin 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Estrogen Replacement Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endometrial Hyperplasia × Metformin × Clear all
NCT02872818 2016-08-23

Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia

Kayseri Education and Research Hospital

Phase 4 Completed
40 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡